29.73
+0.28(+0.95%)
Currency In USD
| Previous Close | 29.45 |
| Open | 29.59 |
| Day High | 30.14 |
| Day Low | 29.01 |
| 52-Week High | 31.95 |
| 52-Week Low | 14.73 |
| Volume | 14.78M |
| Average Volume | 3.42M |
| Market Cap | 5.27B |
| PE | 118.92 |
| EPS | 0.25 |
| Moving Average 50 Days | 26.19 |
| Moving Average 200 Days | 21.78 |
| Change | 0.28 |
If you invested $1000 in BrightSpring Health Services, Inc. Common Stock (BTSG) since IPO date, it would be worth $2,702.73 as of October 18, 2025 at a share price of $29.73. Whereas If you bought $1000 worth of BrightSpring Health Services, Inc. Common Stock (BTSG) shares 6 months ago, it would be worth $1,903.33 as of October 18, 2025 at a share price of $29.73.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
BrightSpring Health Services, Inc. to Announce Third Quarter 2025 Financial Results on October 31, 2025
GlobeNewswire Inc.
Oct 08, 2025 8:05 PM GMT
LOUISVILLE, Ky., Oct. 08, 2025 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. (“BrightSpring” or the “Company”) (NASDAQ: BTSG) announced today that it plans to release its third quarter 2025 financial results on Friday, October 31, 2025, pr
BrightSpring Health Services, Inc. to Announce Second Quarter 2025 Financial Results on August 1, 2025
GlobeNewswire Inc.
Jul 08, 2025 8:05 PM GMT
LOUISVILLE, Ky., July 08, 2025 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. (“BrightSpring” or the “Company”) (NASDAQ: BTSG) announced today that it plans to release its second quarter 2025 financial results on Friday, August 1, 2025, pri
BrightSpring Health Services Announces Onco360® Selected as National Pharmacy Partner for Multiple New Cancer and Rare Disease Drugs
GlobeNewswire Inc.
Jun 18, 2025 8:30 PM GMT
LOUISVILLE, Ky., June 18, 2025 (GLOBE NEWSWIRE) -- BrightSpring Health Services (“BrightSpring” or “BrightSpring Health Services”) (NASDAQ: BTSG) is proud to announce that its specialty pharmacy, Onco360®, has been selected as the national pharmacy